U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Locally Recurrent Uterine Corpus Leiomyosarcoma

MedGen UID:
1791953
•Concept ID:
C5555512
•
Neoplastic Process

Definition

The reemergence of uterine corpus leiomyosarcoma after a period of remission, at or adjacent to the site of the original tumor. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVLocally Recurrent Uterine Corpus Leiomyosarcoma

Professional guidelines

PubMed

Sarcomas and related neoplasms of the uterine corpus--a brief review of their natural history, prognostic factors, and management.
Bard DS, Zuna RE
Obstet Gynecol Annu 1981;10:237-65. PMID: 6269035
Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V, Karlen JR, Piver SM, Tsukada Y, Moore RH
AJR Am J Roentgenol 1976 Jan;126(1):139-47. doi: 10.2214/ajr.126.1.139. PMID: 175673

Recent clinical studies

Etiology

Major clinical research advances in gynecologic cancer in 2015.
Suh DH, Kim M, Kim HJ, Lee KH, Kim JW
J Gynecol Oncol 2016 Nov;27(6):e53. doi: 10.3802/jgo.2016.27.e53. PMID: 27775259Free PMC Article
Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Kao YH, Saad U, Tan AE, Magsombol BM, Padhy AK
Acta Radiol 2011 May 1;52(4):463-6. Epub 2011 Mar 17 doi: 10.1258/ar.2011.100509. PMID: 21498277
p53 expression in neoplasms of the uterine corpus.
Bur ME, Perlman C, Edelmann L, Fey E, Rose PG
Am J Clin Pathol 1992 Jul;98(1):81-7. doi: 10.1093/ajcp/98.1.81. PMID: 1615931
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Park R, Silverberg S
J Clin Oncol 1985 Sep;3(9):1240-5. doi: 10.1200/JCO.1985.3.9.1240. PMID: 3897471

Diagnosis

Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Kao YH, Saad U, Tan AE, Magsombol BM, Padhy AK
Acta Radiol 2011 May 1;52(4):463-6. Epub 2011 Mar 17 doi: 10.1258/ar.2011.100509. PMID: 21498277
Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
Shintaku M, Fukushima A
Pathol Int 2006 Oct;56(10):625-8. doi: 10.1111/j.1440-1827.2006.02018.x. PMID: 16984620
Hormone replacement therapy after uterine leiomyosarcoma treatment. Case reports.
Ursic-Vrscaj M
Eur J Gynaecol Oncol 1999;20(5-6):379-82. PMID: 10609499
Sarcomas and related neoplasms of the uterine corpus--a brief review of their natural history, prognostic factors, and management.
Bard DS, Zuna RE
Obstet Gynecol Annu 1981;10:237-65. PMID: 6269035

Therapy

Major clinical research advances in gynecologic cancer in 2015.
Suh DH, Kim M, Kim HJ, Lee KH, Kim JW
J Gynecol Oncol 2016 Nov;27(6):e53. doi: 10.3802/jgo.2016.27.e53. PMID: 27775259Free PMC Article
Hormone replacement therapy after uterine leiomyosarcoma treatment. Case reports.
Ursic-Vrscaj M
Eur J Gynaecol Oncol 1999;20(5-6):379-82. PMID: 10609499
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Park R, Silverberg S
J Clin Oncol 1985 Sep;3(9):1240-5. doi: 10.1200/JCO.1985.3.9.1240. PMID: 3897471

Prognosis

Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Kao YH, Saad U, Tan AE, Magsombol BM, Padhy AK
Acta Radiol 2011 May 1;52(4):463-6. Epub 2011 Mar 17 doi: 10.1258/ar.2011.100509. PMID: 21498277
p53 expression in neoplasms of the uterine corpus.
Bur ME, Perlman C, Edelmann L, Fey E, Rose PG
Am J Clin Pathol 1992 Jul;98(1):81-7. doi: 10.1093/ajcp/98.1.81. PMID: 1615931
Sarcomas and related neoplasms of the uterine corpus--a brief review of their natural history, prognostic factors, and management.
Bard DS, Zuna RE
Obstet Gynecol Annu 1981;10:237-65. PMID: 6269035
Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V, Karlen JR, Piver SM, Tsukada Y, Moore RH
AJR Am J Roentgenol 1976 Jan;126(1):139-47. doi: 10.2214/ajr.126.1.139. PMID: 175673

Clinical prediction guides

Major clinical research advances in gynecologic cancer in 2015.
Suh DH, Kim M, Kim HJ, Lee KH, Kim JW
J Gynecol Oncol 2016 Nov;27(6):e53. doi: 10.3802/jgo.2016.27.e53. PMID: 27775259Free PMC Article
Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
Shintaku M, Fukushima A
Pathol Int 2006 Oct;56(10):625-8. doi: 10.1111/j.1440-1827.2006.02018.x. PMID: 16984620
Hormone replacement therapy after uterine leiomyosarcoma treatment. Case reports.
Ursic-Vrscaj M
Eur J Gynaecol Oncol 1999;20(5-6):379-82. PMID: 10609499
p53 expression in neoplasms of the uterine corpus.
Bur ME, Perlman C, Edelmann L, Fey E, Rose PG
Am J Clin Pathol 1992 Jul;98(1):81-7. doi: 10.1093/ajcp/98.1.81. PMID: 1615931

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...